Vitamin E-gene interactions in aging and inflammatory age-related diseases: Implications for treatment. A systematic review

Ageing Research Reviews

Volumn 14, Issue 1, 2014, Pages 81-101

  Mocchegiani, Eugenio ^a   Costarelli, Laura ^a   Giacconi, Robertina ^a   Malavolta, Marco ^a   Basso, Andrea ^a   Piacenza, Francesco ^a   Ostan, Rita ^b   Cevenini, Elisa ^b   Gonos, Efstathios S ^c   Franceschi, Claudio ^b   Monti, Daniela ^d  

^a INRCA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUTE OF BIOLOGY   (Greece)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Aging; Antioxidant activity; Immune system; Inflammation; Longevity; Vitamin E gene interactions

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; INTERLEUKIN 2;

AGING; ALPHA TOCOPHEROL DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEMOTAXIS; COGNITIVE DEFECT; CYTOKINE PRODUCTION; DEMENTIA; DIABETES MELLITUS; DIETARY REFERENCE INTAKE; GENE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INFLAMMATORY DISEASE; INFLUENZA; LONGEVITY; LYMPHOCYTE PROLIFERATION; MALABSORPTION; NATURAL KILLER CELL; NEOPLASM; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK REDUCTION; SMOKING; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALIA;

AGING; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; VITAMIN E;

EID: 84897421659     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.01.001     Document Type: Review

References (274)

1. Abdala-Valencia H., Berdnikovs S., Cook-Mills J.M. Vitamin E isoforms differentially regulate intercellular adhesion molecule-1 activation of PKCα in human microvascular endothelial cells. PLoS ONE 2012, 7:e41054-e41058.
2. Abner E.L., Schmitt F.A., Mendiondo M.S., Marcum J.L., Kryscio R.J. Vitamin E and all-cause mortality: a meta-analysis. Curr. Aging Sci. 2011, 4:158-170.
3. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm R.H., Probstfield J.L., Simons-Morton D.G., Friedewald W.T. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008, 358:2545-2559. ACCORD STUDY. Action to Control Cardiovascular Risk in Diabetes Study Group.
4. Cushman W.C., Evans G.W., Byington R.P., Goff D.C., Grimm R.H., Cutler J.A., Simons-Morton D.G., Basile J.N., Corson M.A., Probstfield J.L., Katz L., Peterson K.A., Friedewald W.T., Buse J.B., Bigger J.T., Gerstein H.C., Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 2010, 362:1575-1585. ACCORD STUDY.
5. Ginsberg H.N., Elam M.B., Lovato L.C., Crouse J.R., Leiter L.A., Linz P., Friedewald W.T., Buse J.B., Gerstein H.C., Probstfield J., Grimm R.H., Ismail-Beigi F., Bigger J.T., Goff D.C., Cushman W.C., Simons-Morton D.G., Byington R.P. Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 2010, 362:1563-1574. ACCORD STUDY.
6. Adolfsson O., Huber B.T., Meydani S.N. Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J. Immunol. 2001, 167:3809-3817.
7. Aggarwal B.B., Sundaram C., Prasad S., Kannappan R. Tocotrienols, the Vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem. Pharmacol. 2010, 80:1613-1631.
8. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17589-17594.
9. Arad Y., Goodman K.J., Roth M., Newstein D., Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 2005, 46:158-165.
10. Asleh R., Marsh S., Shilkrut M., Binah O., Guetta J., Lejbkowicz F., Enav B., Shehadeh N., Kanter Y., Lache O., Cohen O., Levy N.S., Levy A.P. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 2003, 92:1193-1200.
11. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 1994, 330:1029-1035. ATBC Study. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group.
12. Aytan N., Jung T., Tamtürk F., Grune T., Kartal-Ozer N. Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors 2008, 33:225-236.
13. Azzi A. Molecular mechanism of alpha-tocopherol action. Free Radic. Biol. Med. 2007, 43:16-21.
14. Azzi A., Stocker A. Vitamin E: non-antioxidant roles. Prog. Lipid Res. 2000, 39:231-255.
15. Azzi A., Gysin R., Kempna P., Munteanu A., Negis Y., Villacorta L., Visarius T., Zingg J.M. Vitamin E mediates cell signaling and regulation of gene expression. Ann. N. Y. Acad. Sci. 2004, 1031:86-95.
16. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 2002, 519:8-10.
17. Bahadorani S., Bahadorani P., Phillips J.P., Hilliker A.J. The effects of vitamin supplementation on Drosophila life span under normoxia and under oxidative stress. J. Gerontol. A, Biol. Sci. Med. Sci. 2008, 63:35-42.
18. Baier G. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol. Rev. 2003, 192:64-79.
19. Bakris G.L. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin. Proc. 2011, 86:444-456.
20. Barella L., Muller P.Y., Schlachter M., Hunziker W., Stocklin E., Spitzer V., Meier N., de Pascual-Teresa S., Minihane A.M., Rimbach G. Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats. Biochem. Biophys. Acta 2004, 1689:66-74.
21. Bartłomiej S., Justyna R.K., Ewa N. Bioactive compounds in cereal grains - occurrence, structure, technological significance and nutritional benefits - a review. Food Sci. Technol. Int. 2012, 18:559-568.
22. Barve A., Khor T.O., Nair S., Reuhl K., Suh N., Reddy B., Newmark H., Kong A.N. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int. J. Cancer 2009, 124:1693-1699.
23. Battaini F., Pascale A. Protein kinase C signal transduction regulation in physiological and pathological aging. Ann. N. Y. Acad. Sci. 2005, 1057:177-192.
24. Beharka A.A., Wu D., Serafini M., Meydani S.N. Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite. Free Radic. Biol. Med. 2002, 32:503-511.
25. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 1992, 186:944-950.
26. Belisle S.E., Leka L.S., Delgado-Lista J., Jacques P.F., Ordovas J.M., Meydani S.N. Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. J. Nutr. 2009, 139:1855-1860.
27. Biesalski H.K., Grune T., Tinz J., Zollner I., Blumberg J.B. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients 2010, 2:929-949.
28. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 3. Art. No: CD007176.
29. Blum S., Asaf R., Guetta J., Miller-Lotan R., Asleh R., Kremer R., Levy N.S., Berger F.G., Aronson D., Fu X., Zhang R., Hazen S.L., Levy A.P. Haptoglobin genotype determines myocardial infarct size in diabetic mice. J. Am. Coll. Cardiol. 2007, 49:82-87.
30. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000, 356:1213-1218.
31. Boothby L.A., Doering P.L. Vitamin C and vitamin E for Alzheimer's disease. Ann. Pharmacother. 2005, 39:2073-2080.
32. Borel P., Moussa M., Reboul E., Lyan B., Defoort C., Vincent-Baudry S., Maillot M., Gastaldi M., Darmon M., Portugal H., Planells R., Lairon D. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J. Nutr. 2007, 137:2653-2659.
33. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 1991, 266:6188-6194.
34. Boyd S.D. Everything you wanted to know about small RNA but were afraid to ask. Lab. Invest. 2008, 88:569-578.
35. Brewer G.J. Why vitamin E therapy fails for treatment of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:27-30.
36. Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 2003, 305:737-740.
37. Brigelius-Flohe R. Adverse effects of vitamin E by induction of drug metabolism. Genes Nutr. 2007, 2:249-256.
38. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. FASEB J. 1999, 13:1145-1155.
39. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., Azzi A. The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 2002, 76:703-716.
40. Bromley D., Anderson P.C., Daggett V. Structural consequences of mutations to the alpha-tocopherol transfer protein associated with the neurodegenerative disease ataxia with vitamin E deficiency. Biochemistry 2013, 52:4264-4273.
41. Burton G.W., Cheeseman K.H., Doba T., Ingold K.U., Slater T.F. Vitamin E as an antioxidant in vitro and in vivo. Ciba Found. Symp. 1983, 101:4-18.
42. Burton G.W., Cheng S.C., Webb A., Ingold K.U. Vitamin E in young and old human red blood cells. Biochem. Biophys. Acta 1986, 860:84-90.
43. Campisi J. Cancer, aging and cellular senescence. In Vivo 2000, 14:183-188.
44. Cao G., Booth S.L., Sadowski J.A., Prior R.L. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am. J. Clin. Nutr. 1998, 68:1081-1087.
45. Carr A.C., Zhu B.Z., Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 2000, 87:349-354.
46. Casoli T., Di Stefano G., Delfino A., Fattoretti P., Bertoni-Freddari C. Vitamin E deficiency and aging effect on expression levels of GAP-43 and MAP-2 in selected areas of the brain. Ann. N. Y. Acad. Sci. 2004, 1019:37-40.
47. Catalgol B., Batirel S., Ozer N.K. Cellular protection and therapeutic potential of tocotrienols. Curr. Pharm. Des. 2011, 17:2215-2220.
48. Catalgol B., Kartal-Ozer N. Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis. Curr. Cardiol. Rev. 2010, 6:309-324.
49. Chan A.C. Partners in defense, vitamin E and vitamin C. Can. J. Physiol. Pharmacol. 1993, 71:725-731.
50. Chen M.F., Hsu H.C., Liau C.S., Lee Y.T. Vitamin E supplementation attenuates myointimal proliferation of the abdominal aorta after balloon injury in diet-induced hypercholesterolemic rabbits. Prostaglandins Other Lipid Mediat. 1998, 56:219-238.
51. Cherubini A., Martin A., Andres-Lacueva C., Di Iorio A., Lamponi M., Mecocci P., Bartali B., Corsi A., Senin U., Ferrucci L. Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study. Neurobiol. Aging 2005, 26:987-994.
52. Cherubini A., Zuliani G., Costantini F., Pierdomenico S.D., Volpato S., Mezzetti A., Mecocci P., Pezzuto S., Bregnocchi M., Fellin R., Senin U. High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. J. Am. Geriatr. Soc. 2001, 49:651-654. VASA Study Group.
53. Chin S.F., Hamid N.A., Latiff A.A., Zakaria Z., Mazlan M., Yusof Y.A., Karim A.A., Ibahim J., Hamid Z., Ngah W.Z. Reduction of DNA damage in older healthy adults by Tri E Tocotrienol supplementation. Nutrition 2008, 24:1-10.
54. Chin S.F., Ibahim J., Makpol S., Abdul Hamid N.A., Abdul Latiff A., Zakaria Z., Mazlan M., Mohd Yusof Y.A., Abdul Karim A., Wan Ngah W.Z. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: a randomized controlled study. Nutr. Metab. 2011, 8:42-50.
55. Cipriano C., Caruso C., Lio D., Giacconi R., Malavolta M., Muti E., Gasparini N., Franceschi C., Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 2005, 32:13-18.
56. Clarke M.W., Burnett J.R., Croft K.D. Vitamin E in human health and disease. Crit. Rev. Clin. Lab. Sci. 2008, 45:417-450.
57. Claycombe K.J., Meydani S.N. Vitamin E and genome stability. Mutat. Res. 2001, 475:37-44.
58. Coquette A., Vray B., Vanderpas J. Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage. Arch. Int. Physiol. Biochim. 1986, 94:S29-S34.
59. Cyrus T., Yao Y., Rokach J., Tang L.X., Praticò D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 2003, 107:521-523.
60. Daynes R.A., Enioutina E.Y., Jones D.C. Role of redox imbalance in the molecular mechanisms responsible for immunosenescence. Antioxid. Redox Signal. 2003, 5:537-548.
61. de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001, 357:89-95. Collaborative Group of the Primary Prevention Project.
62. De la Fuente M., Hernanz A., Guayerbas N., Victor V.M., Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic. Res. 2008, 42:272-280.
63. De Taeye B., Smith L.H., Vaughan D.E. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol. 2005, 5:149-154.
64. de Winther M.P., van Dijk K.W., Havekes L.M., Hofker M.H. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2000, 20:290-297.
65. Devaraj S., Jialal I. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1125-1133.
66. Devaraj S., Hugou I., Jialal I. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. J. Lipid Res. 2001, 42:521-527.
67. Di Donato I., Bianchi S., Federico A. Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol. Sci. 2010, 31:511-515.
68. Di Iorio A., Cherubini A., Volpato S., Sparvieri E., Lauretani F., Franceschi C., Senin U., Abate G., Paganelli R., Martin A., Andres-Lacueva C., Ferrucci L. Markers of inflammation, vitamin E and peripheral nervous system function: the InCHIANTI study. Neurobiol. Aging 2006, 27:1280-1288.
69. Dimmeler S., Nicotera P. MicroRNAs in age-related diseases. EMBO Mol. Med. 2013, 5:180-190.
70. Döring F., Rimbach G., Lodge J.K. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life 2004, 56:615-620.
71. Ekstrand-Hammarstrom B., Osterlund C., Lilliehook B., Bucht A. Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells. Clin. Exp. Immunol. 2007, 147:359-369.
72. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287:3223-3229.
73. Ernst I.M., Pallauf K., Bendall J.K., Paulsen L., Nikolai S., Huebbe P., Roeder T., Rimbach G. Vitamin E supplementation and lifespan in model organisms. Ageing Res. Rev. 2013, 12:365-375.
74. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
75. Farina N., Isaac M.G., Clark A.R., Rusted J., Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev. 2012, 11:1-31. Art. No: CD002854.
76. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105:1049-1056.
77. Fischer A., Gaedicke S., Frank J., Doring F., Rimbach G. Dietary vitamin E deficiency does not affect global and specific DNA methylation patterns in rat liver. Br. J. Nutr. 2010, 104:935-940.
78. Fischer A., Pallauf J., Gohil K., Weber S.U., Packer L., Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem. Biophys. Res. Commun. 2001, 285:470-475.
79. Forbes J.M., Cooper M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013, 93:137-188.
80. Fortin C.F., Larbi A., Lesur O., Douziech N., Fulop T. Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J. Leukoc. Biol. 2006, 79:1061-1072.
81. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflammaging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
82. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
83. Frank J., Chin X.W., Schrader C., Eckert G.P., Rimbach G. Do tocotrienols have potential as neuroprotective dietary factors?. Ageing Res. Rev. 2012, 11:163-180.
84. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R., Dartigues J.F., Lobo A., Martinez-Lage J., Soininen H., Hofman A. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54:S10-S15.
85. Fruebis J., Silvestre M., Shelton D., Napoli C., Palinski W. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J. Lipid Res. 1999, 40:1958-1966.
86. Fuhrman B., Volkova N., Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase. Atherosclerosis 2002, 161:307-316.
87. Fulop T., Douziech N., Larbi A., Dupuis G. The role of lipid rafts in T lymphocyte signal transduction with aging. Ann. N. Y. Acad. Sci. 2002, 973:302-304.
88. Gaedicke S., Zhang X., Schmelzer C., Lou Y., Doering F., Frank J., Rimbach G. Vitamin E dependent microRNA regulation in rat liver. FEBS Lett. 2008, 582:3542-3546.
89. Goldenstein H., Levy N.S., Lipener Y.T., Levy A.P. Patient selection and vitamin E treatment in diabetes mellitus. Expert Rev. Cardiovasc. Ther. 2013, 11:319-326.
90. Goodman Y., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 1994, 128:1-12.
91. Goodwin J.S., Webb D.R. Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol. 1980, 15:106-122.
92. Graat J.M., Schouten E.G., Kok F.J. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002, 288:715-721.
93. Gray B., Swick J., Ronnenberg A.G. Vitamin E and adiponectin: proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutr. Rev. 2011, 69:155-161.
94. Grubic N., Stegnar M., Peternel P., Kaider A., Binder B.R. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Thromb. Res. 1996, 84:431-443.
95. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.GiSSI study Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
96. Hahn T., Akporiaye E.T. Repeat dose study of the novel proapoptotic chemotherapeutic agent alpha-tocopheryloxy acetic acid in mice. Anticancer Drugs 2012, 23:455-464.
97. Han S.N., Meydani S.N. Antioxidants, cytokines, and influenza infection in aged mice and elderly humans. J. Infect. Dis. 2000, 182(Suppl. 1):S74-S80.
98. Han S.N., Meydani M., Wu D., Bender B.S., Smith D.E., Vina J., Cao G., Prior R.L., Meydani S.N. Effect of long-term dietary antioxidant supplementation on influenza virus infection. J. Gerontol. A, Biol. Sci. Med. Sci. 2000, 55:B496-B503.
99. Hara H., Kato H., Kogure K. Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res. 1990, 510:335-338.
100. Harman D. Free radical theory of aging: dietary implications. Am. J. Clin. Nutr. 1972, 25:839-843.
101. Harman D. Secondary amyloidosis and antioxidants. Lancet 1980, 2:593.
102. Harman D. Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009. Biogerontology 2009, 10:773-781.
103. Harrington L.A., Harley C.B. Effect of vitamin E on lifespan and reproduction in Caenorhabditis elegans. Mech. Ageing Dev. 1988, 43:71-78.
104. Hayek M.G., Taylor S.F., Bender B.S., Han S.N., Meydani M., Smith D.E., Eghtesada S., Meydani S.N. Vitamin E supplementation decreases lung virus titers in mice infected with influenza. J. Infect. Dis. 1997, 176:273-276.
105. Hemila H., Kaprio J. Vitamin E and respiratory tract infections in elderly persons. JAMA 2004, 292:2834. author reply 2834.
106. Hemila H., Kaprio J. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake. Br. J. Nutr. 2008, 100:896-902.
107. Hemila H., Kaprio J. Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C. Am. J. Epidemiol. 2009, 169:946-953.
108. Hemila H., Virtamo J., Albanes D., Kaprio J. Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers. Chest 2004, 125:557-565.
109. Hemila H., Kaprio J. Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking. Age Ageing 2011, 40:215-220.
110. Hodis H.N., Mack W.J., LaBree L., Mahrer P.R., Sevanian A., Liu C.R., Liu C.H., Hwang J., Selzer R.H., Azen S.P. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002, 106:1453-1459. VEAPS Research Group.
111. Hsiao K.K. Understanding the biology of beta-amyloid precursor proteins in transgenic mice. Neurobiol. Aging 1995, 16:705-706.
112. Huang H.Y., Helzlsouer K.J., Appel L.J. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol. Biomarkers Prev. 2000, 9:647-652.
113. Huebbe P., Jofre-Monseny L., Boesch-Saadatmandi C., Minihane A.M., Rimbach G. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice. J. Physiol. Pharmacol. 2007, 58:683-698.
114. Ichitani Y., Okaichi H., Yoshikawa T., Ibata Y. Learning behaviour in chronic vitamin E-deficient and -supplemented rats: radial arm maze learning and passive avoidance response. Behav. Brain Res. 1992, 51:157-164.
115. Irizarry M.C., Raman R., Schwarzschild M.A., Becerra L.M., Thomas R.G., Peterson R.C., Ascherio A., Aisen P.S. Plasma urate and progression of mild cognitive impairment. Neurodegener. Dis. 2009, 6:23-28.
116. Iuliano L., Mauriello A., Sbarigia E., Spagnoli L.G., Violi F. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation 2000, 101:1249-1254.
117. Jiang Q., Christen S., Shigenaga M.K., Ames B.N. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 2001, 74:714-722.
118. Jiang Q., Elson-Schwab I., Courtemanche C., Ames B.N. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11494-11499.
119. Jofre-Monseny L., de Pascual-Teresa S., Plonka E., Huebbe P., Boesch-Saadatmandi C., Minihane A.M., Rimbach G. Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages. Br. J. Nutr. 2007, 97:864-871.
120. Jofre-Monseny L., Minihane A.M., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008, 52:131-145.
121. Ju J., Picinich S.C., Yang Z., Zhao Y., Suh N., Kong A.N., Yang C.S. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010, 31:533-542.
122. Kaga E., Karademir B., Baykal A.T., Ozer N.K. Identification of differentially expressed proteins in atherosclerotic aorta and effect of vitamin E. J. Proteomics 2013, 92:260-273.
123. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
124. Kamat J.P., Devasagayam T.P. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci. Lett. 1995, 195:179-182.
125. Kamat J.P., Sarma H.D., Devasagayam T.P., Nesaretnam K., Basiron Y. Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes. Mol. Cell. Biochem. 1997, 170:131-137.
126. Kanaya Y., Doi T., Sasaki H., Fujita A., Matsuno S., Okamoto K., Nakano Y., Tsujiwaki S., Furuta H., Nishi M., Tsuno T., Taniguchi H., Nanjo K. Rice bran extract prevents the elevation of plasma peroxylipid in KKAy diabetic mice. Diabetes Res. Clin. Pract. 2004, 66(Suppl. 1):S157-S160.
127. Karasu C., Ozansoy G., Bozkurt O., Erdoǧan D., Omeroǧlu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 1997, 46:872-879.
128. Kataja-Tuomola M.K., Kontto J.P., Mannisto S., Albanes D., Virtamo J. Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur. J. Clin. Nutr. 2011, 65:590-597.
129. 2 production in keratinocytes induced by UVB, IL-1β and peroxidants. Bioorg. Med. Chem. 2011, 19:6348-6355.
130. Klein E.A., Thompson I.M., Tangen C.M., Crowley J.J., Lucia M.S., Goodman P.J., Minasian L.M., Ford L.G., Parnes H.L., Gaziano J.M., Karp D.D., Lieber M.M., Walther P.J., Klotz L., Parsons J.K., Chin J.L., Darke A.K., Lippman S.M., Goodman G.E., Meyskens F.L., Baker L.H. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011, 306:1549-1556.
131. Koppal T., Subramaniam R., Drake J., Prasad M.R., Dhillon H., Butterfield D.A. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 1998, 786:270-273.
132. Kowdley K.V., Mason J.B., Meydani S.N., Cornwall S., Grand R.J. Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption. Gastroenterology 1992, 102:2139-2142.
133. Kuusisto J., Laakso M. Update on type 2 diabetes as a cardiovascular disease risk equivalent. Curr. Cardiol. Rep. 2013, 15:331-335.
134. Lagrost L., Desrumaux C., Masson D., Deckert V., Gambert P. Structure and function of the plasma phospholipid transfer protein. Curr. Opin. Lipidol. 1998, 9:203-209.
135. Landrier J.F., Gouranton E., El Yazidi C., Malezet C., Balaguer P., Borel P., Amiot M.J. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Endocrinology 2009, 150:5318-5325.
136. Larbi A., Kempf J., Pawelec G. Oxidative stress modulation and T cell activation. Exp. Gerontol. 2007, 42:852-858.
137. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294:56-65.
138. Lemaire-Ewing S., Desrumaux C., Neel D., Lagrost L. Vitamin E transport, membrane incorporation and cell metabolism: is alpha-tocopherol in lipid rafts an oar in the lifeboat?. Mol. Nutr. Food Res. 2010, 54:631-640.
139. Leuner K., Pantel J., Frey C., Schindowski K., Schulz K., Wegat T., Maurer K., Eckert A., Muller W.E. Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J. Neural Transm. 2007, 72:207-215.
140. Levy A.P., Asleh R., Blum S., Levy N.S., Miller-Lotan R., Kalet-Litman S., Anbinder Y., Lache O., Nakhoul F.M., Asaf R., Farbstein D., Pollak M., Soloveichik Y.Z., Strauss M., Alshiek J., Livshits A., Schwartz A., Awad H., Jad K., Goldenstein H. Haptoglobin: basic and clinical aspects. Antioxid. Redox Signal. 2010, 12:293-304.
141. Lin M.T., Beal M.F. Alzheimer's APP mangles mitochondria. Nat. Med. 2006, 12:1241-1243.
142. Liochev S.I. Reactive oxygen species and the free radical theory of aging. Free Radic. Biol. Med. 2013, 60:1-4.
143. Lipman R.D., Bronson R.T., Wu D., Smith D.E., Prior R., Cao G., Han S.N., Martin K.R., Meydani S.N., Meydani M. Disease incidence and longevity are unaltered by dietary antioxidant supplementation initiated during middle age in C57BL/6 mice. Mech. Ageing Dev. 1998, 103:269-284.
144. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A., Parsons J.K., Bearden J.D., Crawford E.D., Goodman G.E., Claudio J., Winquist E., Cook E.D., Karp D.D., Walther P., Lieber M.M., Kristal A.R., Darke A.K., Arnold K.B., Ganz P.A., Santella R.M., Albanes D., Taylor P.R., Probstfield J.L., Jagpal T.J., Crowley J.J., Meyskens F.L., Baker L.H., Coltman C.A. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
145. Lirangi M., Meydani M., Zingg J.M., Azzi A. α-Tocopheryl-phosphate regulation of gene expression in preadipocytes and adipocytes. Biofactors 2012, 38:450-457.
146. Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 2013, 9:106-118.
147. Lloret A., Badia M.C., Mora N.J., Pallardo F.V., Alonso M.D., Vina J. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis. 2009, 17:143-149.
148. Lohmiller J.J., Roellich K.M., Toledano A., Rabinovitch P.S., Wolf N.S., Grossmann A. Aged murine T-lymphocytes are more resistant to oxidative damage due to the predominance of the cells possessing the memory phenotype. J. Gerontol. A, Biol. Sci. Med. Sci. 1996, 51:B132-B140.
149. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., Dagenais G.R. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347. HOPE and HOPE-TOO Trial Investigators.
150. Losonczy K.G., Harris T.B., Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the established populations for epidemiologic studies of the elderly. Am. J. Clin. Nutr. 1996, 64:190-196.
151. Lu G., Xiao H., Li G.X., Picinich S.C., Chen Y.K., Liu A., Lee M.J., Loy S., Yang C.S. A gamma-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis 2010, 31:687-694.
152. Mahabir S., Schendel K., Dong Y.Q., Barrera S.L., Spitz M.R., Forman M.R. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int. J. Cancer 2008, 123:1173-1180.
153. Malatesta M., Bertoni-Freddari C., Fattoretti P., Caporaloni C., Fakan S., Gazzanelli G. Altered RNA structural constituents in aging and vitamin E deficiency. Mech. Ageing Dev. 2003, 124:175-181.
154. Mangialasche F., Kivipelto M., Mecocci P., Rizzuto D., Palmer K., Winblad B., Fratiglioni L. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J. Alzheimers Dis. 2010, 20:1029-1037.
155. Marchioli R., Levantesi G., Macchia A., Marfisi R.M., Nicolosi G.L., Tavazzi L., Tognoni G., Valagussa F. Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. J. Cardiovasc. Med. 2006, 7:347-350. GISSI-Prevenzione Investigators.
156. Marko M.G., Ahmed T., Bunnell S.C., Wu D., Chung H., Huber B.T., Meydani S.N. Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. J. Immunol. 2007, 178:1443-1449.
157. Martin A., Foxall T., Blumberg J.B., Meydani M. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler. Thromb. Vasc. Biol. 1997, 17:429-436.
158. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
159. Mazlan M., Sue Mian T., Mat Top G., Zurinah Wan Ngah W. Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes. J. Neurol. Sci. 2006, 243:5-12.
160. Mecocci P., Polidori M.C., Troiano L., Cherubini A., Cecchetti R., Pini G., Straatman M., Monti D., Stahl W., Sies H., Franceschi C., Senin U. Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic. Biol. Med. 2000, 28:1243-1248.
161. Meier M., King G.L. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc. Med. 2000, 5:173-185.
162. Meydani M. Vitamin E. Lancet 1995, 345:170-175.
163. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J. Nutr. 2001, 131:366S-368S.
164. Meydani M., Macauley J.B., Blumberg J.B. Effect of dietary vitamin E and selenium on susceptibility of brain regions to lipid peroxidation. Lipids 1988, 23:405-409.
165. Meydani S.N., Barklund M.P., Liu S., Meydani M., Miller R.A., Cannon J.G., Morrow F.D., Rocklin R., Blumberg J.B. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am. J. Clin. Nutr. 1990, 52:557-563.
166. Meydani S.N., Han S.N., Hamer D.H. Vitamin E and respiratory infection in the elderly. Ann. N. Y. Acad. Sci. 2004, 1031:214-222.
167. Meydani S.N., Han S.N., Wu D. Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol. Rev. 2005, 205:269-284.
168. Meydani S.N., Meydani M., Blumberg J.B. Antioxidants and the aging immune response. Adv. Exp. Med. Biol. 1990, 262:57-67.
169. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Pedrosa M., Diamond R., Schaefer E.J. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am. J. Clin. Nutr. 1998, 68:311-318.
170. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Siber G., Loszewski R., Thompson C., Pedrosa M.C., Diamond R.D., Stollar B.D. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 1997, 277:1380-1386.
171. Miller E.R., Erlinger T.P., Sacks F.M., Svetkey L.P., Charleston J., Lin P.H., Appel L.J. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis 2005, 183:175-182.
172. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142:37-46.
173. Milman U., Blum S., Shapira C., Aronson D., Miller-Lotan R., Anbinder Y., Alshiek J., Bennett L., Kostenko M., Landau M., Keidar S., Levy Y., Khemlin A., Radan A., Levy A.P. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler. Thromb. Vasc. Biol. 2008, 28:341-347.
174. Mocchegiani E., Costarelli L., Giacconi R., Piacenza F., Basso A., Malavolta M. Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Res. Rev. 2012, 11:297-319.
175. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 2002, 37:349-357.
176. Molano A., Huang Z., Marko M.G., Azzi A., Wu D., Wang E., Kelly S.L., Merrill A.H., Bunnell S.C., Meydani S.N. Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunction. PLoS ONE 2012, 7:e47650.
177. Molano A., Meydani S.N. Vitamin E, signalosomes and gene expression in T cells. Mol. Aspects Med. 2012, 33:55-62.
178. Monji A., Morimoto N., Okuyama I., Yamashita N., Tashiro N. Effect of dietary vitamin E on lipofuscin accumulation with age in the rat brain. Brain Res. 1994, 634:62-68.
179. Morley A.A., Trainor K.J. Lack of an effect of vitamin E on lifespan of mice. Biogerontology 2001, 2:109-112.
180. Morris M.C. Nutritional determinants of cognitive aging and dementia. Proc. Nutr. Soc. 2012, 71:1-13.
181. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., Scherr P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr. 2005, 81:508-514.
182. Munteanu A., Zingg J.M., Ogru E., Libinaki R., Gianello R., West S., Negis Y., Azzi A. Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation. Biochem. Biophys. Res. Commun. 2004, 318:311-316.
183. Murphy T.H., Schnaar R.L., Coyle J.T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 1990, 4(6):1624-1633.
184. Mustacich D.J., Leonard S.W., Devereaux M.W., Sokol R.J., Traber M.G. Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic. Biol. Med. 2006, 41:1069-1078.
185. Nanayakkara P.W., van Guldener C., ter Wee P.M., Scheffer P.G., van Ittersum F.J., Twisk J.W., Teerlink T., van Dorp W., Stehouwer C.D. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch. Intern. Med. 2007, 167:1262-1270.
186. Navarro A., Gomez C., Sanchez-Pino M.J., Gonzalez H., Bandez M.J., Boveris A.D., Boveris A. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R1392-R1399.
187. Nesaretnam K., Guthrie N., Chambers A.F., Carroll K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 1995, 30:1139-1143.
188. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33:461-469.
189. Niki E., Traber M.G. A history of vitamin E. Ann. Nutr. Metab. 2012, 61:207-212.
190. O'Leary K.A., de Pascual-Tereasa S., Needs P.W., Bao Y.P., O'Brien N.M., Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutation Res. 2004, 551:245-254.
191. Ozen M., Creighton C.J., Ozdemir M., Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008, 27:1788-1793.
192. Ozer N.K., Negis Y., Aytan N., Villacorta L., Ricciarelli R., Zingg J.M., Azzi A. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis 2006, 184:15-20.
193. Pae M., Meydani S.N., Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. 2012, 3:91-129.
194. Palace V.P., Hill M.F., Farahmand F., Singal P.K. Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation 1999, 99:121-126.
195. Palace V., Kumar D., Hill M.F., Khaper N., Singal P.K. Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J. Mol. Cell. Cardiol. 1999, 31:193-202.
196. Pallast E.G., Schouten E.G., de Waart F.G., Fonk H.C., Doekes G., von Blomberg B.M., Kok F.J. Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am. J. Clin. Nutr. 1999, 69:1273-1281.
197. Patrignani P., Panara M.R., Tacconelli S., Seta F., Bucciarelli T., Ciabattoni G., Alessandrini P., Mezzetti A., Santini G., Sciulli M.G., Cipollone F., Davi G., Gallina P., Bon G.B., Patrono C. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 2000, 102:539-545.
198. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 2005, 352:2379-2388. Alzheimer's Disease Cooperative Study Group.
199. Petratos S., Li Q.X., George A.J., Hou X., Kerr M.L., Unabia S.E., Hatzinisiriou I., Maksel D., Aguilar M.I., Small D.H. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008, 131:90-108.
200. Peyser C.E., Folstein M., Chase G.A., Starkstein S., Brandt J., Cockrell J.R., Bylsma F., Coyle J.T., McHugh P.R., Folstein S.E. Trial of d-alpha-tocopherol in Huntington's disease. Am. J. Psychiatry 1995, 152:1771-1775.
201. Pham D.Q., Plakogiannis R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: part 2. Ann. Pharmacother. 2005, 39:2065-2072.
202. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today 1991, 12:349-352.
203. Pierpaoli E., Viola V., Barucca A., Orlando F., Galli F., Provinciali M. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice. Carcinogenesis 2013, 34:1352-1360.
204. Pierpaoli E., Viola V., Pilolli F., Piroddi M., Galli F., Provinciali M. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression. Life Sci. 2010, 86:668-675.
205. Poljsak B., Milisav I. The neglected significance of "antioxidative stress". Oxid. Med. Cell. Longev. 2012, 2012:480895-480907.
206. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med. 1998, 4:1189-1192.
207. Puglielli L., Tanzi R.E., Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 2003, 6:345-351.
208. Qureshi A.A., Sami S.A., Salser W.A., Khan F.A. Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J. Nutr. Biochem. 2001, 12:318-329.
209. Qureshi A.A., Qureshi N., Hasler-Rapacz J.O., Weber F.E., Chaudhary V., Crenshaw T.D., Gapor A., Ong A.S., Chong Y.H., Peterson D. Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am. J. Clin. Nutr. 1991, 53:1042S-1046S.
210. Reiter E., Jiang Q., Christen S. Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol. Aspects Med. 2007, 28:668-691.
211. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000, 102:82-87.
212. Rigotti A. Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects Med. 2007, 28:423-436.
213. Rimbach G., Fischer A., Stoecklin E., Barella L. Modulation of hepatic gene expression by alpha-tocopherol in cultured cells and in vivo. Ann. N. Y. Acad. Sci. 2004, 1031:102-108.
214. Rimbach G., Moehring J., Huebbe P., Lodge J.K. Gene-regulatory activity of alpha-tocopherol. Molecules 2010, 15:1746-1761.
215. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 1993, 328:1450-1456.
216. Robinson C., Woo S., Walsh A., Nowak A.K., Lake R.A. The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma. Nutr. Cancer 2012, 64:315-322.
217. Rota C., Rimbach G., Minihane A.M., Stoecklin E., Barella L. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr. Neurosci. 2005, 8:21-29.
218. Sabat R., Kolleck I., Witt W., Volk H., Sinha P., Rustow B. Immunological dysregulation of lung cells in response to vitamin E deficiency. Free Radic. Biol. Med. 2001, 30:1145-1153.
219. Saito Y., Nishio K., Akazawa Y.O., Yamanaka K., Miyama A., Yoshida Y., Noguchi N., Niki E. Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: tocopherols and tocotrienols exert similar effects by antioxidant function. Free Radic. Biol. Med. 2010, 49:1542-1549.
220. Salonen J.T., Nyyssönen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Lakka T.A., Rissanen T., Leskinen L., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Poulsen H.E. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J. Intern. Med. 2000, 248:377-386.
221. Salonen R.M., Nyyssönen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Lakka H.M., Vanharanta M., Salonen J.T., Poulsen H.E. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003, 107:947-953. Antioxidant Supplementation in Atherosclerosis Prevention Study.
222. Sanchez C., Perez M., Avila J. GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. Eur. J. Cell Biol. 2000, 79:252-260.
223. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 1997, 336:1216-1222.
224. Saremi A., Arora R. Vitamin E and cardiovascular disease. Am. J. Ther. 2010, 17:e56-e65.
225. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., Bubes V., Manson J.E., Glynn R.J., Gaziano J.M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
226. Singal P.K., Khaper N., Palace V., Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res. 1998, 40:426-432.
227. Sirikci O., Ozer N.K., Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 1996, 126:253-263.
228. Slevin M., Krupinski J., Badimon L. Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J. Angiogenes Res. 2009, 21:1-4.
229. Socci D.J., Crandall B.M., Arendash G.W. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res. 1995, 693:88-94.
230. Squier T.C. Oxidative stress and protein aggregation during biological aging. Exp. Gerontol. 2001, 36:1539-1550.
231. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 1993, 328:1444-1449.
232. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781-786.
233. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 1996, 19:53-77.
234. Suzuki Y.J., Packer L. Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 1993, 193:277-283.
235. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001, 32:181-184.
236. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A. d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:12190-12194.
237. Terasawa Y., Manabe H., Yoshida N., Uemura M., Sugimoto N., Naito Y., Yoshikawa T., Kondo M. Alpha-tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein. Biofactors 2000, 11:221-233.
238. Testa R., Bonfigli A.R., Sirolla C., Boemi M., Manfrini S., Mari D., Testa I., Sacchi E., Franceschi C. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients. Diabetes Nutr. Metab. 2004, 17:217-221.
239. Theriault A., Chao J.T., Wang Q., Gapor A., Adeli K. Tocotrienol: a review of its therapeutic potential. Clin. Biochem. 1999, 32:309-319.
240. Thomas D.R. Vitamins in aging, health, and longevity. Clin. Interv. Aging 2006, 1:81-91.
241. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., Fabbri M., Alder H., Liu C.G., Calin G.A., Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 2007, 179:5082-5089.
242. Tiwari V., Kuhad A., Bishnoi M., Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol. Biochem. Behav. 2009, 93:183-189.
243. Traber M.G., Kayden H.J. Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am. J. Clin. Nutr. 1989, 49:517-526.
244. Tseng C.F., Lin C.C., Huang H.Y., Liu H.C., Mao S.J. Antioxidant role of human haptoglobin. Proteomics 2004, 4:2221-2228.
245. Usoro O.B., Mousa S.A. Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences. Crit. Rev. Food Sci. Nutr. 2010, 50:414-419.
246. van Amsterdam J., van der Horst-Graat J., Bischoff E., Steerenberg P., Opperhuizen A., Schouten E. The effect of vitamin E supplementation on serum DHEA and neopterin levels in elderly subjects. Int. J. Vitam. Nutr. Res. 2005, 75:327-331.
247. Vardi M., Blum S., Levy A.P. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur. J. Int. Med. 2012, 23:628-632.
248. Villanueva C., Kross R.D. Antioxidant-induced stress. Int. J. Mol. Sci. 2012, 13:2091-2109.
249. Vina J., Borras C., Mohamed K., Garcia-Valles R., Gomez-Cabrera M.C. The free radical theory of ageing revisited. The cell signaling disruption theory of aging. Antioxid. Redox Signal. 2013, 19:779-787.
250. Viola V., Pilolli F., Piroddi M., Pierpaoli E., Orlando F., Provinciali M., Betti M., Mazzini F., Galli F. Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E. Genes Nutr. 2012, 7:29-41.
251. Virtamo J., Rapola J.M., Ripatti S., Heinonen O.P., Taylor P.R., Albanes D., Huttunen J.K. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch. Intern. Med. 1998, 158:668-675.
252. Voegele A.F., Jerković L., Wellenzohn B., Eller P., Kronenberg F., Liedl K.R., Dieplinger H. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry 2002, 41:14532-14538.
253. Wan Nazaimoon W.M., Khalid B.A. Tocotrienols-rich diet decreases advanced glycosylation end-products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic rats. Malays. J. Pathol. 2002, 24:77-82.
254. Waters D.D., Alderman E.L., Hsia J., Howard B.V., Cobb F.R., Rogers W.J., Ouyang P., Thompson P., Tardif J.C., Higginson L., Bittner V., Steffes M., Gordon D.J., Proschan M., Younes N., Verter J.I. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002, 288:2432-2440.
255. Way K.J., Katai N., King G.L. Protein kinase C and the development of diabetic vascular complications. Diabetic Med. 2001, 18:945-959.
256. Webb D.R., Rogers T.J., Ong S., Steiner A. Detection of prostaglandin induced antigen-stimulated changes in splenic AMP levels by immunofluorescence. Prostaglandins Med. 1980, 5:141-148.
257. Weber P., Bendich A., Machlin L.J. Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997, 13:450-460.
258. Wigg S.J., Tare M., Forbes J., Cooper M.E., Thomas M.C., Coleman H.A., Parkington H.C., O'Brien R.C. Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia 2004, 47:1038-1046.
259. Wolvers D.A., van Herpen-Broekmans W.M., Logman M.H., van der Wielen R.P., Albers R. Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study. Nutr. J. 2006, 5:28-35.
260. Wortwein G., Stackman R.W., Walsh T.J. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A. Exp. Neurol. 1994, 125:15-21.
261. Wray D.W., Nishiyama S.K., Harris R.A., Zhao J., McDaniel J., Fjeldstad A.S., Witman M.A., Ives S.J., Barrett-O'Keefe Z., Richardson R.S. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension 2012, 59:818-824.
262. Wu D., Meydani S.N. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J. Leukoc. Biol. 2008, 84:900-914.
263. Wu D., Koga T., Martin K.R., Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999, 147:297-307.
264. Wu D., Mura C., Beharka A.A., Han S.N., Paulson K.E., Hwang D., Meydani S.N. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am. J. Physiol. 1998, 275:C661-C668.
265. Yamaoka S., Kim H.S., Ogihara T., Oue S., Takitani K., Yoshida Y., Tamai H. Severe Vitamin E deficiency exacerbates acute hyperoxic lung injury associated with increased oxidative stress and inflammation. Free Radic. Res. 2008, 42:602-612.
266. Yang C.S., Suh N. Cancer prevention by different forms of tocopherols. Top. Curr. Chem. 2013, 329:21-33.
267. Yoshida Y., Niki E., Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem. Phys. Lipids 2003, 123:63-75.
268. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000, 342:154-160.
269. Zapolska-Downar D., Zapolski-Downar A., Markiewski M., Ciechanowicz A., Kaczmarczyk M., Naruszewicz M. Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 2000, 274:609-615.
270. Zhou Y., Gopalakrishnan V., Richardson J.S. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 1996, 67:1419-1425.
271. Zingg J.M., Azzi A., Meydani M. Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr. Rev. 2008, 66:406-414.
272. Zingg J.M., Han S.N., Pang E., Meydani M., Meydani S.N., Azzi A. In vivo regulation of gene transcription by alpha- and gamma-tocopherol in murine T lymphocytes. Arch. Biochem. Biophys. 2013, 538:111-119.
273. Zingg J.M., Ricciarelli R., Andorno E., Azzi A. Novel 5' exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 2002, 22:412-417.
274. Zou S., Sinclair J., Wilson M.A., Carey J.R., Liedo P., Oropeza A., Kalra A., de Cabo R., Ingram D.K., Longo D.L., Wolkow C.A. Comparative approaches to facilitate the discovery of prolongevity interventions: effects of tocopherols on lifespan of three invertebrate species. Mech. Ageing Dev. 2007, 128(2):222-226.